TY - JOUR
T1 - Menstrual- and gender-dependent variations in circulating IL-1 agonists, antagonists, and binding proteins
AU - Cannon, Joseph G.
AU - Abad, Leslie W.
AU - Vannier, Edouard
AU - Lynch, Elizabeth A.
PY - 1998
Y1 - 1998
N2 - This study tested the hypotheses that sex-related differences in circulating binding proteins for interleukin-1β (IL-1β) exist and that these binding proteins affect immunoassays for IL-1β and IL-1Ra. 125I- labeled IL-1β was added to human plasma samples, then chromatographed. The percentages of total radioactivity eluting in a high-molecular-weight peak were 21.0 + 0.8 for men (n = 6), 19.1 ± 0.9 for follicular phase women (n = 6), and 18.0 ± 0.8 in luteal phase women (n = 6; men vs. women, P = 0.032; follicular vs. luteal, P = 0.035), and correlated with plasma sIL-1RII concentrations (r = 0.647, P = 0.007). Plasma IL-1β immunoreactivity did not correspond to concurrent cellular secretion rates due, in part, to interference in the IL-1β assay by sIL-1RII. Correspondence between plasma IL-1Ra levels and cellular secretion rates was observed only after serial dilutions of the samples. These results indicate that plasma IL-1β binding capacity differs between men and women and that sIL-1RII is a major contributing factor. Furthermore, relating plasma IL-1 isoform immunoreactivity to functional measures (tracer binding) or concurrent release by isolated cells can lead to insights about assay interferences that may exist in plasma.
AB - This study tested the hypotheses that sex-related differences in circulating binding proteins for interleukin-1β (IL-1β) exist and that these binding proteins affect immunoassays for IL-1β and IL-1Ra. 125I- labeled IL-1β was added to human plasma samples, then chromatographed. The percentages of total radioactivity eluting in a high-molecular-weight peak were 21.0 + 0.8 for men (n = 6), 19.1 ± 0.9 for follicular phase women (n = 6), and 18.0 ± 0.8 in luteal phase women (n = 6; men vs. women, P = 0.032; follicular vs. luteal, P = 0.035), and correlated with plasma sIL-1RII concentrations (r = 0.647, P = 0.007). Plasma IL-1β immunoreactivity did not correspond to concurrent cellular secretion rates due, in part, to interference in the IL-1β assay by sIL-1RII. Correspondence between plasma IL-1Ra levels and cellular secretion rates was observed only after serial dilutions of the samples. These results indicate that plasma IL-1β binding capacity differs between men and women and that sIL-1RII is a major contributing factor. Furthermore, relating plasma IL-1 isoform immunoreactivity to functional measures (tracer binding) or concurrent release by isolated cells can lead to insights about assay interferences that may exist in plasma.
KW - Assay validation
KW - Soluble receptors
KW - α2-macroglobulin
UR - http://www.scopus.com/inward/record.url?scp=0031942753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031942753&partnerID=8YFLogxK
U2 - 10.1002/jlb.63.1.117
DO - 10.1002/jlb.63.1.117
M3 - Article
C2 - 9469481
AN - SCOPUS:0031942753
SN - 0741-5400
VL - 63
SP - 117
EP - 123
JO - Journal of Leukocyte Biology
JF - Journal of Leukocyte Biology
IS - 1
ER -